Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) growth of a m...

Daiichi pays Merck $170M to create bronchi cancer cells T-cell engager treaty

.Merck &amp Co. has swiftly redeemed a number of the costs of its own Javelin Therapies acquistion, ...

BioMarin standstills preclinical gene therapy for heart condition

.After BioMarin carried out a spring clean of its pipeline in April, the business has decided that i...

Eisai vegetations molecular adhesive SEED along with $1.5 B biobucks work

.Huge Pharmas remain stuck to the suggestion of molecular adhesive degraders. The current business t...

Life science credit organization reveals with $600M

.A brand-new worldwide lifestyle scientific research credit organization, referred to Symbiotic Fund...

BMS trenches TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another large bet from the Caforio time, canceling a deal fo...

Nuvation halts BET inhibitor after taking into consideration stage 1 information

.After having a look at stage 1 record, Nuvation Biography has actually determined to halt focus on ...

' Scientific intuition' led FDA consultants to back Zevra's unusual disease med

.Zevra Rehabs' unusual health condition drug seems to be on the course to confirmation this fall aft...

Pfizer takes $230M hit after axing neglected DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment failing has actually blown a $230 t...

AC Immune observes 'landmark' possible in Alzheimer's medication data

.After greater than two decades of work on neurodegenerative health conditions, Swiss biotech hvac I...